Newsroom

Sorted by: Latest

-

D-Lysine Monohydrochloride (CAS 7274-88-6) Industry Research 2025: Global Market Trends 2019-2024 and Forecasts 2025-2029 - Applications, Manufacturing Method, Patents, Suppliers, Prices, End-users - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "D-Lysine Monohydrochloride (CAS 7274-88-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on D-Lysine monohydrochloride provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves...
-

KPMG geht strategische Partnerschaft mit Uniphore ein, um KI-Agenten auf Basis branchenspezifischer kleiner Sprachmodelle zu entwickeln

PALO ALTO, Kalifornien--(BUSINESS WIRE)--Uniphore, das Business-KI-Unternehmen, gab heute eine strategische Partnerschaft mit KPMG LLP bekannt, um KI-Agenten in internen und kundenorientierten Arbeitsabläufen einzusetzen und damit die kontinuierlichen Bemühungen des Unternehmens zu unterstützen, von experimentellen KI-Pilotprojekten zu einer produktionsreifen Bereitstellung überzugehen. Im Rahmen der Zusammenarbeit wird KPMG gemeinsam mit Uniphore KI-Agenten entwickeln, die die Business AI Clou...
-

Potassium Permanganate (CAS 7722-64-7) Industry Research Report 2025: Global Market Trends 2019-2024 and Forecasts 2025-2029 - Applications, Manufacturing Method, Patents, Suppliers, Prices, End-users - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Potassium Permanganate (CAS 7722-64-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Potassium permanganate provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vi...
-

Albuterol Sulfate (CAS 51022-70-9) Industry Research 2025: Global Market Trends 2019-2024 and Forecasts 2025-2029 - Applications, Manufacturing Method, Patents, Suppliers, Prices, End-users - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Albuterol Sulfate (CAS 51022-70-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Albuterol sulfate provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resou...
-

Massachusetts Financial Services Company UK Regulatory Announcement: Form 8.3 - Amendment

LONDON--(BUSINESS WIRE)--  FORM 8.3 Amendment – This form replaces Rule 8.3 Form published at 12:10 PM 16 January 2026, changes made to section 1(f) and 2(a). PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if differen...
-

Massachusetts Financial Services Company UK Regulatory Announcement: Form 8.3 - Amendment

LONDON--(BUSINESS WIRE)--  FORM 8.3 Amendment – This form replaces Rule 8.3 Form published at 1:02 PM 14 January 2026, changes made to section 1(f) and 2(a). PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different...
-

Massachusetts Financial Services Company UK Regulatory Announcement: Form 8.3 - Amendment

LONDON--(BUSINESS WIRE)--  FORM 8.3 Amendment – This form replaces Rule 8.3 Form published at 12:42 PM 15 January 2026, changes made to section 1(f) and 2(a). PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if differen...
-

Deadline Soon: Jayud Global Logistics Limited (JYD) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming January 20, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Jayud Global Logistics Limited (“Jayud” or the “Company”) (NASDAQ: JYD) securities between April 21, 2023 and April 30, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON JAYUD GLOBAL LOGISTICS LIMITED (JYD), CLICK HERE TO PAR...
-

SpineGuard Reports Its Full-year 2025 Revenue

PARIS & BOULDER, Colo.--(BUSINESS WIRE)--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology, which measures the electrical conductivity of tissues in real time at the local level to secure and simplify the placement of bone implants, today announced its revenue for the fiscal year ended December 31, 2025. Pierre Jérôme, Chairman, CEO and co-founder of SpineGuard, said: " The actions taken in 2025 to adapt our co...
-

SpineGuard publie son chiffre d’affaires annuel 2025

PARIS & BOULDER, Colorado--(BUSINESS WIRE)--Regulatory News: SpineGuard (FR0011464452 – ALSGD, éligible PEA-PME), entreprise innovante qui déploie sa technologie digitale de guidage chirurgical (DSG®) par mesure locale de la conductivité électrique des tissus en temps réel pour sécuriser et simplifier le placement d’implants osseux, annonce aujourd’hui son chiffre d’affaires pour l’exercice clos au 31 décembre 2025. Pierre Jérôme, Président Directeur Général et Co-Fondateur de SpineGuard, décla...